Effect of exercise on lipolysis in adipose tissue

Future Lipidology

Volumn 3, Issue 5, 2008, Pages 557-572

  Polak, Jan ^a   Bajzova, Magda ^a   Stich, Vladimir ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Adipose tissue; Aerobic training; Catecholamines; Exercise; Lipolysis; Strength training

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ATRIAL NATRIURETIC FACTOR; BETA 3 ADRENERGIC RECEPTOR; CATECHOLAMINE; CYTOKINE; FATTY ACID; GROWTH HORMONE; HYDROCORTISONE; INSULIN; INTERLEUKIN 6; NONSTERIFIED FATTY ACID; UNCLASSIFIED DRUG;

ACROMEGALY; ADIPOCYTE; ADIPOSE TISSUE; AEROBIC EXERCISE; BODY FAT DISTRIBUTION; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE RELEASE; CYTOKINE PRODUCTION; FATTY ACID METABOLISM; FEMALE; GLUCOSE HOMEOSTASIS; GROWTH HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; KINESIOTHERAPY; LIPID METABOLISM; LIPID OXIDATION; LIPID STORAGE; LIPOLYSIS; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SUBCUTANEOUS FAT;

EID: 55849128550     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460875.3.5.557     Document Type: Review

References (203)

1. Helmrich SP, Ragland DR, Paffenbarger RS Jr: Prevention of non-insulin-dependent diabetes mellitus with physical activity. Med. Sci. Sports Exerc. 26(7), 824-830 (1994).
2. Blair SN, Kohl HW III, Barlow CE, Paffenbarger RS Jr, Gibbons LW, Macera CA: Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA 273(14), 1093-1098 (1995).
3. Macera CA, Hootman JM, Sniezek JE: Major public health benefits of physical activity. Athritis Rheum. 49(1), 122-128 (2003).
4. Macera CA, Powell KE: Population attributable risk: implications of physical activity dose. Med. Sci. Sports Exerc. 33(6 Suppl.), S635-S639 (2001).
5. Wannamethee SG, Shaper AG, Walker M: Physical activity and mortality in older men with diagnosed coronary heart disease. Circulation 102(12), 1358-1363 (2000).
6. Gregg EW, Gerzoff RB, Caspersen CJ, Williamson DF, Narayan KM: Relationship of walking to mortality among US adults with diabetes. Arch. Intern. Med. 163(12), 1440-1447 (2003).
7. Lee IM: Physical activity and cancer prevention - data from epidemiologic studies. Med. Sci. Sports Exerc. 35(11), 1823-1827 (2003).
8. Hayes C, Kriska A: Role of physical activity in diabetes management and prevention. J. Am. Diet. Assoc. 108(4 Suppl. 1), S19-S23 (2008).
9. Smith SC Jr: Multiple risk factors for cardiovascular disease and diabetes mellitus. Am. J. Med. 120(3 Suppl. 1), S3-S11 (2007).
10. Onat A, Avci GS, Barlan MM, Uyarel H, Uzunlar B, Sansoy V: Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int. J. Obes. Relat. Metab. Disord. 28(8), 1018-1025 (2004).
11. Ross R, Fortier L, Hudson R: Separate associations between visceral and subcutaneous adipose tissue distribution, insulin and glucose levels in obese women. Diabetes Care 19(12), 1404-1411 (1996).
12. Hotamisligil GS: Inflammation and metabolic disorders. Nature 444(7121), 860-867 (2006).
13. Van Gaal LF, Mertens IL, De Block CE: Mechanisms linking obesity with cardiovascular disease. Nature 444(7121), 875-880 (2006).
14. Jeukendrup AE: Regulation of fat metabolism in skeletal muscle. Ann. NY Acad. Sci. 967, 217-235 (2002).
15. Bickerton AS, Roberts R, Fielding BA et al.: Preferential uptake of dietary fatty acids in adipose tissue and muscle in the postprandial period. Diabetes 56(1), 168-176 (2007).
16. Horowitz JF: Exercise-induced alterations in muscle lipid metabolism improve insulin sensitivity. Exerc. Sport Sci. Rev. 35(4), 192-196 (2007).
17. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD: Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37(8), 1020-1024 (1988).
18. Baldeweg SE, Golay A, Natali A, Balkau B, Del Prato S, Coppack SW: Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR). Eur. J. Clin. Invest. 30(1), 45-52 (2000).
19. Sleeman MW, Donegan NP, Heller-Harrison R, Lane WS, Czech MP: Association of acyl-CoA synthetase-1 with GLUT4-containing vesicles. J. Biol. Chem. 273(6), 3132-3135 (1998).
20. Muoio DM, Newgard CB: Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and β-cell failure in Type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9(3), 193-205 (2008).
21. Guilherme A, Virbasius JV, Puri V, Czech MP: Adipocyte dysfunctions linking obesity to insulin resistance and Type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9(5), 367-377 (2008).
22. Randle PJ, Garland PB, Hales CN, Newsholme EA: The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1(7285), 785-789 (1963).
23. Furukawa H, Carroll RJ, Swift HH, Steiner DF: Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic β-cell line MIN6. Diabetes 48(7), 1395-1401 (1999).
24. Yaney GC, Korchak HM, Corkey BE: Long-chain acyl CoA regulation of protein kinase C and fatty acid potentiation of glucose-stimulated insulin secretion in clonal β-cells. Endocrinology 141(6), 1989-1998 (2000).
25. Zimmermann R, Strauss JG, Haemmerle G et al.: Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306(5700), 1383-1386 (2004).
26. Langin D, Dicker A, Tavernier G et al.: Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 54(11), 3190-3197 (2005).
27. Lafontan M, Bousquet-Melou A, Galitzky J et al.: Adrenergic receptors and fat cells: differential recruitment by physiological amines and homologous regulation. Obes. Res. 3(Suppl. 4), 507S-514S (1995).
28. Arner P: Adrenergic receptor function in fat cells. Am. J. Clin. Nutr. 55(Suppl. 1), 228S-236S (1992).
29. 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br. J. Pharmacol. 117(5), 907-913 (1996).
30. 1-antagonists. J. Lipid Res. 29(5), 587-601 (1988).
31. 3-adrenoceptor agonist in humans. Diabetes 47(10), 1555-1561 (1998).
32. 3-adrenergic stimulation of human thermogenesis and lipid use. Clin. Pharmacol Ther. 67(5), 558-566 (2000).
33. 3-adrenergic effect on lipolysis in human subcutaneous adipose tissue. J. Clin. Endocrinol. Metab. 77(2), 352-355 (1993).
34. 1-adrenergic lipolytic activity in subcutaneous adipose tissue of obese subjects. J. Pharmacol. Exp. Ther. 301(1), 229-233 (2002).
35. 2-adrenoceptors: the regulation of fat cell function and lipolysis. Endocr. Rev. 16(6), 716-738 (1995).
36. Horowitz JF: Fatty acid mobilization from adipose tissue during exercise. Trends Endocrinol. Metab. 14(8), 386-392 (2003).
37. 2-adrenergic receptors by epinephrine during exercise in human adipose tissue. Am. J. Physiol. 277(4 Pt 2), R1076-R1083 (1999).
38. Mauriege P, Despres JP, Marcotte M et al.: Abdominal fat cell lipolysis, body fat distribution, and metabolic variables in premenopausal women J. Clin. Endocrinol. Metab. 71(4), 1028-1035 (1990).
39. 2-adrenergic receptor mRNA levels in adipose tissue of obese women. J. Clin. Endocrinol. Metab. 87(3), 1274-1281 (2002).
40. Mohamed-Ali V, Goodrick S, Rawesh A et al.: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J. Clin. Endocrinol. Metab. 82(12), 4196-4200 (1997).
41. Polak J, Moro C, Klimcakova E et al.: Dynamic strength training improves insulin sensitivity and functional balance between adrenergic α2A and β pathways in subcutaneous adipose tissue of obese subjects. Diabetologia 48(12), 2631-2640 (2005).
42. 2-adrenergic receptors impairs exercise-induced lipolysis in SCAT of obese subjects. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279(2), R499-R504 (2000).
43. 2-adrenergic receptors blunts epinephrine-induced lipolysis in subcutaneous adipose tissue during a hyperinsulinemic euglycemic clamp in men. Am. J. Physiol. Endocrinol. Metab. 285(3), E599-E607 (2003).
44. 2-adrenoceptors in human adipose tissue. Int. J. Obes. 5(6), 651-657 (1981).
45. Moro C, Pillard F, De Glisezinski I et al.: Sex differences in lipolysis-regulating mechanisms in overweight subjects: effect of exercise intensity. Obesity (Silver Spring) 15(9), 2245-2255 (2007).
46. Lindberg UB, Crona N, Silfverstolpe G, Bjorntorp P, Rebuffe-Scrive M: Regional adipose tissue metabolism in postmenopausal women after treatment with exogenous sex steroids. Horm. Metab. Res. 22(6), 345-351 (1990).
47. Blaak E: Gender differences in fat metabolism. Curr. Opin. Clin. Nutr. Metab. Care 4(6), 499-502 (2001).
48. Polak J, Moro C, Klimcakova E et al.: The atrial natriuretic peptide- and catecholamine-induced lipolysis and expression of related genes in adipose tissue in hypothyroid and hyperthyroid patients. Am. J. Physiol. Endocrinol. Metab. 293(1), E246-E251 (2007).
49. 2- and β-adrenergic receptor binding and action in gluteal adipocytes from patients with hypothyroidism and hyperthyroidism. Metabolism 36(11), 1031-1039 (1987).
50. Arner P, Wennlund A, Ostman J: Regulation of lipolysis by human adipose tissue in hyperthyroidism. J. Clin. Endocrinol. Metab. 48(3), 415-419 (1979).
51. Pucci E, Chiovato L, Pinchera A: Thyroid and lipid metabolism. Int. J. Obes. Relat. Metab. Disord. 24(Suppl. 2), S109-S112 (2000).
52. McMurray RG, Hackney AC: Interactions of metabolic hormones, adipose tissue and exercise. Sports Med. 35(5), 393-412 (2005).
53. Hoffstedt J, Arner P, Hellers G, Lonnqvist F: Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men. J. Lipid Res. 38(4), 795-804 (1997).
54. Hoffstedt J, Folkesson R, Wahrenberg H, Wennlund A, van Harmelen V, Arner P: A marked upregulation of uncoupling protein 2 gene expression in adipose tissue of hyperthyroid subjects. Horm. Metab. Res. 32(11-12), 475-479 (2000).
55. 2-adrenoceptor binding sites in human fat cells from various fat deposits: functional consequences. Eur. J. Clin. Invest. 17(2), 156-165 (1987).
56. Yu J, Yu HC, Kim KA et al.: Differences in the amount of lipolysis induced by atrial natriuretic peptide in small and large adipocytes. J. Pept. Sci. 14(8), 972-977 (2008).
57. Garaulet M, Hernandez-Morante JJ, Lujan J, Tebar FJ, Zamora S: Relationship between fat cell size and number and fatty acid composition in adipose tissue from different fat depots in overweight/obese humans. Int. J. Obes. (Lond.) 30(6), 899-905 (2006).
58. Farnier C, Krief S, Blache M et al.: Adipocyte functions are modulated by cell size change: potential involvement of an integrin/ERK signalling pathway. Int. J. Obes. Relat. Metab. Disord. 27(10), 1178-1186 (2003).
59. 2-adrenergic antilipolytic effect during exercise in subcutaneous adipose tissue of trained men. J. Appl. Physiol. 91(4), 1760-1765 (2001).
60. Numao S, Hayashi Y, Katayama Y et al.: Effects of obesity phenotype on fat metabolism in obese men during endurance exercise. Int. J. Obes. (Lond.) 30(8), 1189-1196 (2006).
61. Ezell DM, Geiselman PJ, Anderson AM et al.: Substrate oxidation and availability during acute exercise in non-obese, obese, and post-obese sedentary females. Int. J. Obes. Relat. Metab. Disord. 23(10), 1047-1056 (1999).
62. Wade AJ, Marbut MM, Round JM: Muscle fibre type and aetiology of obesity. Lancet 335(8693), 805-808 (1990).
63. Blaak EE: Basic disturbances in skeletal muscle fatty acid metabolism in obesity and Type 2 diabetes mellitus. Proc. Nutr. Soc. 63(2), 323-330 (2004).
64. Blaak EE: Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance. Best Pract. Res. Clin. Endocrinol. Metab. 19(3), 391-403 (2005).
65. Hellstrom L, Blaak E, Hagstrom-Toft E: Gender differences in adrenergic regulation of lipid mobilization during exercise. Int. J. Sports Med. 17(6), 439-447 (1996).
66. Arner P, Kriegholm E, Engfeldt P, Bolinder J: Adrenergic regulation of lipolysis in situ at rest and during exercise. J. Clin. Invest. 85(3), 893-898 (1990).
67. Richterova B, Stich V, Moro C et al.: Effect of endurance training on adrenergic control of lipolysis in adipose tissue of obese women. J. Clin. Endocrinol. Metab. 89(3), 1325-1331 (2004).
68. Wahrenberg H, Lonnqvist F, Arner P: Mechanisms underlying regional differences in lipolysis in human adipose tissue. J. Clin. Invest. 84(2), 458-467 (1989).
69. Rosenbaum M, Presta E, Hirsch J, Leibel RL: Regional differences in adrenoreceptor status of adipose tissue in adults and prepubertal children. J. Clin. Endocrinol. Metab. 73(2), 341-347 (1991).
70. Guo Z, Johnson CM, Jensen MD: Regional lipolytic responses to isoproterenol in women. Am. J. Physiol. 273(1 Pt 1), E108-E112 (1997).
71. Berman DM, Nicklas BJ, Rogus EM, Dennis KE, Goldberg AP: Regional differences in adrenoceptor binding and fat cell lipolysis in obese, postmenopausal women. Metabolism 47(4), 467-473 (1998).
72. Lafontan M, Dang-Tran L, Berlan M: α-adrenergic antilipolytic effect of adrenaline in human fat cells of the thigh: comparison with adrenaline responsiveness of different fat deposits. Eur. J. Clin. Invest. 9(4), 261-266 (1979).
73. Large V, Arner P: Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab. 24(5), 409-418 (1998).
74. Votruba SB, Jensen MD: Regional fat deposition as a factor in FFA metabolism. Annu. Rev. Nutr. 27, 149-163 (2007).
75. Moro C, Crampes F, Sengenes C et al.: Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans. FASEB J. 18(7), 908-910 (2004).
76. Djurhuus CB, Gravholt CH, Nielsen S, Pedersen SB, Moller N, Schmitz O: Additive effects of cortisol and growth hormone on regional and systemic lipolysis in humans. Am. J. Physiol. Endocrinol. Metab. 286(3), E488-E494 (2004).
77. Enevoldsen LH, Polak J, Simonsen L et al.: Post-exercise abdominal, subcutaneous adipose tissue lipolysis in fasting subjects is inhibited by infusion of the somatostatin analogue octreotide. Clin. Physiol. Funct. Imaging 27(5), 320-326 (2007).
78. Pedersen BK, Steensberg A, Fischer C et al.: The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor? Proc. Nutr. Soc. 63(2), 263-267 (2004).
79. Cawthorn WP, Sethi JK: TNF-α and adipocyte biology. FEBS Lett 582(1), 117-131 (2008).
80. Djurhuus CB, Gravholt CH, Nielsen S et al.: Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans. Am. J. Physiol. Endocrinol. Metab. 283(1), E172-E177 (2002).
81. Sengenes C, Berlan M, De Glisezinski I, Lafontan M, Galitzky J: Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J. 14(10), 1345-1351 (2000).
82. Moro C, Pillard F, De Glisezinski I et al.: Exercise-induced lipid mobilization in subcutaneous adipose tissue is mainly dependent on natriuretic peptides in overweight men. Am. J. Physiol. Endocrinol. Metab. 295, E505-E513 (2008).
83. Sengenes C, Bouloumie A, Hauner H et al.: Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J. Biol. Chem. 278(49), 48617-48626 (2003).
84. Galitzky J, Sengenes C, Thalamas C et al.: The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men. J. Lipid Res. 42(4), 536-544 (2001).
85. Sengenes C, Stich V, Berlan M et al.: Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women. Int. J. Obes. Relat. Metab. Disord. 26(1), 24-32 (2002).
86. Lafontan M, Moro C, Berlan M, Crampes F, Sengenes C, Galitzky J: Control of lipolysis by natriuretic peptides and cyclic GMP. Trends Endocrinol. Metab. 19(4), 130-137 (2008).
87. Moro C, Polak J, Hejnova J et al.: Atrial natriuretic peptide stimulates lipid mobilization during repeated bouts of endurance exercise. Am. J. Physiol. Endocrinol. Metab. 290(5), E864-E869 (2006).
88. Moro C, Polak J, Richterova B et al.: Differential regulation of atrial natriuretic peptide- and adrenergic receptor-dependent lipolytic pathways in human adipose tissue. Metabolism 54(1), 122-131 (2005).
89. McGrath MF, de Bold ML, de Bold AJ: The endocrine function of the heart. Trends Endocrinol. Metab. 16(10), 469-477 (2005).
90. Lee CY, Burnett JC Jr: Natriuretic peptides and therapeutic applications. Heart Fail. Rev. 12(2), 131-142 (2007).
91. Stokes K: Growth hormone responses to sub-maximal and sprint exercise. Growth Horm. IGF Res. 13(5), 225-238 (2003).
92. Pritzlaff CJ, Wideman L, Weltman JY et al.: Impact of acute exercise intensity on pulsatile growth hormone release in men. J. Appl. Physiol. 87(2), 498-504 (1999).
93. Moller N, Gjedsted J, Gormsen L, Fuglsang J, Djurhuus C: Effects of growth hormone on lipid metabolism in humans. Growth Horm. IGF Res. 13(Suppl. A), S18-S21 (2003).
94. Mulla NA, Simonsen L, Bulow J: Post-exercise adipose tissue and skeletal muscle lipid metabolism in humans: the effects of exercise intensity. J. Physiol. 524(Pt 3), 919-928 (2000).
95. Van Hall G, Bülow J, Sacchetti M, Al Mulla N, Lyngsr D, Simonsen L: Regional fat metabolism in splanchnic and adipose tissues; the effect of exercise. J. Physiol. 543(3), 1033-1046 (2002).
96. Sakharova AA, Horowitz JF, Surya S et al.: Role of growth hormone in regulating lipolysis, proteolysis, and hepatic glucose production during fasting. J. Clin. Endocrinol. Metab. 93(7), 2755-2759 (2008).
97. Widdowson WM, Gibney J: The effect of growth hormone replacement on exercise capacity in patients with GH-deficiency: a meta-analysis. J. Clin. Endocrinol. Metab. DOI: 10.1210/jc.2008-1239 (2008).
98. Thomas SG, Woodhouse LJ, Pagura SM, Ezzat S: Ventilation threshold as a measure of impaired physical performance in adults with growth hormone excess. Clin. Endocrinol. (Oxf.) 56(3), 351-358 (2002).
99. Colao A, Cuocolo A, Marzullo P et al.: Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly. J. Clin. Enaocrinol. Metab. 84(1), 17-23 (1999).
100. Ottosson M, Vikman-Adolfsson K, Enerback S, Olivecrona G, Bjorntorp P: The effects of cortisol on the regulation of lipoprotein lipase activity in human adipose tissue. J. Clin. Endocrinol. Metab. 79(3), 820-825 (1994).
101. Ottosson M, Lonnroth P, Bjorntorp P, Eden S: Effects of cortisol and growth hormone on lipolysis in human adipose tissue. J. Clin. Endocrinol. Metab. 85(2), 799-803 (2000).
102. Samra JS, Clark ML, Humphreys SM, MacDonald IA, Bannister PA, Frayn KN: Effects of physiological hypercortisolemia on the regulation of lipolysis in subcutaneous adipose tissue. J. Clin. Endocrinol. Metab. 83(2), 626-631 (1998).
103. Divertie GD, Jensen MD, Miles JM: Stimulation of lipolysis in humans by physiological hypercortisolemia. Diabetes 40(10), 1228-1232 (1991).
104. Greco AV, Mingrone G, Giancaterini A et al.: Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51(1), 144-151 (2002).
105. Zeyda M, Stulnig TM: Adipose tissue macrophages. Immunol. Lett. 112(2), 61-67 (2007).
106. Wang P, Mariman E, Renes J, Keijer J: The secretory function of adipocytes in the physiology of white adipose tissue. J. Cell. Physiol. 216(1), 3-13 (2008).
107. Trujillo ME, Scherer PE: Adipose tissue-derived factors: impact on health and disease. Endocr. Rev. 27(7), 762-778 (2006).
108. Pedersen BK, Steensberg A, Schjerling P: Muscle-derived interleukin-6: possible biological effects. J. Physiol. 536(Pt 2), 329-337 (2001).
109. van Hall G, Steensberg A, Sacchetti M et al.: Interleukin-6 stimulates lipolysis and fat oxidation in humans. J. Clin. Endocrinol. Metab. 88(7), 3005-3010 (2003).
110. Arner P: Insulin resistance in Type 2 diabetes - role of the adipokines. Curr. Mol. Med. 5(3), 333-339 (2005).
111. Zou C, Shao J: Role of adipocytokines in obesity-associated insulin resistance. J. Nutr. Biochem. 19(5), 277-286 (2008).
112. Petersen AM, Pedersen BK: The role of IL-6 in mediating the anti-inflammatory effects of exercise. J. Physiol. Pharmacol. 57(Suppl. 10), 43-51 (2006).
113. Steensberg A, Keller C, Starkie RL, Osada T, Febbraio MA, Pedersen BK: IL-6 and TNF-α expression in, and release from, contracting human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 283(6), E1272-E1278 (2002).
114. Febbraio MA, Steensberg A, Starkie RL, McConell GK, Kingwell BA: Skeletal muscle interleukin-6 and tumor necrosis factor-α release in healthy subjects and patients with Type 2 diabetes at rest and during exercise. Metabolism 52(7), 939-944 (2003).
115. Helge JW, Stallknecht B, Pedersen BK, Galbo H, Kiens B, Richter EA: The effect of graded exercise on IL-6 release and glucose uptake in human skeletal muscle. J. Physiol. 546(Pt 1), 299-305 (2003).
116. Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, Klarlund PB: Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase its plasma interleukin-6. J. Physiol. 529(Pt 1), 237-242 (2000).
117. Starkie RL, Arkinstall MJ, Koukoulas I, Hawley JA, Febbraio MA: Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. J. Physiol. 533(Pt 2), 585-591 (2001).
118. Nehlsen-Cannarella SL, Fagoaga OR, Nieman DC et al.: Carbohydrate and the cytokine response to 2.5 h of running. J. Appl. Physiol. 82(5), 1662-1667 (1997).
119. Nieman DC, Nehlsen-Cannarella SL, Fagoaga OR et al.: Influence of mode and carbohydrate on the cytokine response to heavy exertion. Med. Sci. Sports Exerc. 30(5), 671-678 (1998).
120. Steensberg A, Febbraio MA, Osada T et al.: Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J. Physiol. 537(Pt 2), 633-639 (2001).
121. Stouthard JM, Romijn JA, Van der Poll T et al.: Endocrinologic and metabolic effects of interleukin-6 in humans. Am. J. Physiol. 268(5 Pt 1), E813-E819 (1995).
122. Kanemaki T, Kitade H, Kaibori M et al.: Interleukin 1β and interleukin 6, but not tumor necrosis factor α, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes. Hepatology 27(5), 1296-1303 (1998).
123. Kanda T, Takahashi T: Interleukin-6 and cardiovascular diseases. Jpn. Heart J. 45(2), 183-193 (2004).
124. Ruderman NB, Keller C, Richard AM et al.: Interleukin-6 regulation of AMP-activated protein kinase. Potential role in the systemic response to exercise and prevention of the metabolic syndrome. Diabetes 55(Suppl. 2), S48-S54 (2006).
125. Hoene M, Weigert C: The role of interleukin-6 in insulin resistance, body fat distribution and energy balance. Obes. Rev. 9(1), 20-29 (2008).
126. Bastard JP, Jardel C, Bruckert E et al.: Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J. Clin. Endocrinol. Metab. 85(9), 3338-3342 (2000).
127. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE: Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes. Res. 9(7), 414-417 (2001).
128. Morisset AS, Huot C, Legare D, Tchernof A: Circulating IL-6 concentrations and abdominal adipocyte isoproterenol-stimulated lipolysis in women. Obesity (Silver Spring) 16(7), 1487-1492 (2008).
129. Fried SK, Bunkin DA, Greenberg AS: Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83(3), 847-850 (1998).
130. Simpson KA, Singh MA: Effects of exercise on adiponectin: a systematic review. Obesity (Silver Spring) 16(2), 241-256 (2008).
131. Hulver MW, Houmard JA: Plasma leptin and exercise: recent findings. Sports Med. 33(7), 473-482 (2003).
132. Campbell PJ, Carlson MG, Hill JO, Nurjhan N: Regulation of free fatty acid metabolism by insulin in humans: role of lipolysis and reesterification. Am. J. Physiol. 263(6 Pt 1), E1063-E1069 (1992).
133. Eriksson H, Ridderstrale M, Degerman E et al.: Evidence for the key role of the adipocyte cGMP-inhibited cAMP phosphodiesterase in the antilipolytic action of insulin. Biochim. Biophys. Acta 1266(1), 101-107 (1995).
134. Jensen MD: Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity (Silver Spring) 14(Suppl. 1), 20S-24S (2006).
135. Charles MA, Eschwege E, Thibult N et al.: The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study. Diabetologia 40(9), 1101-1106 (1997).
136. Engfeldt P, Hellmer J, Wahrenberg H, Arner P: Effects of insulin on adrenoceptor binding and the rate of catecholamine-induced lipolysis in isolated human fat cells. J. Biol. Chem. 263(30), 15553-15560 (1988).
137. Lin EC: Glycerol utilization and its regulation in mammals. Annu. Rev. Biochem. 46, 765-795 (1977).
138. Arner P, Ostman J: Mono-acid diacylglycerols in human adipose tissue. Biochim. Biophys. Acta 369(2), 209-221 (1974).
139. Jocken JW, Roepstorff C, Goossens GH et al.: HSL serine phosphorylation and glycerol exchange across skeletal muscle in lean and obese subjects: effect of β-adrenergic stimulation. Diabetes 57(7), 1834-1841(2008).
140. Arner P, Bolinder J: Microdialysis of adipose tissue. J. Intern. Med. 230(4), 381-386 (1991).
141. Bergeron R, Kjaer M, Simonsen L, Bulow J, Galbo H: Glucose production during exercise in humans: a-hv balance and isotopic-tracer measurements compared. J. Appl. Physiol. 87(1), 111-115 (1999).
142. Stallknecht B, Dela F, Helge JW: Are blood flow and lipolysis in subcutaneous adipose tissue influenced by contractions in adjacent muscles in humans? Am. J. Physiol. Endocrinol. Metab. 292(2), E394-E399 (2007).
143. Enevoldsen LH, Simonsen L, MacDonald IA, Bulow J: The combined effects of exercise and food intake on adipose tissue and splanchnic metabolism. J. Physiol. 561(Pt 3), 871-882 (2004).
144. Stallknecht B: Results and discussion. In: Influence of Physical Training on Adipose Tissue Metabolism - with Special Focus on Effects Of Insulin and Epinephrine. The Panum Institute, Copenhagen, Denmark 33-34 (2003)
145. Klimcakova E, Polak J, Moro C et al.: Dynamic strength training improves insulin sensitivity without altering plasma levels and gene expression of adipokines in subcutaneous adipose tissue in obese men. J. Clin. Endocrinol. Metab. 91(12), 5107-5112 (2006).
146. Johnston AP, De Lisio M, Parise G: Resistance training, sarcopenia, and the mitochondrial theory of aging. Appl. Physiol. Nutr. Metab. 33(1), 191-199 (2008).
147. Bartlo P: Evidence-based application of aerobic and resistance training in patients with congestive heart failure. J. Cardiopulm. Rehabil. Prev. 27(6), 368-375 (2007).
148. Willey KA, Singh MA: Battling insulin resistance in elderly obese people with Type 2 diabetes: bring on the heavy weights. Diabetes Care 26(5), 1580-1588 (2003).
149. Deschenes MR, Kraemer WJ: Performance and physiologic adaptations to resistance training. Am. J. Phys. Med. Rehabil. 81(11 Suppl.), S3-S16 (2002).
150. Kraemer WJ, Adams K, Cafarelli E et al. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med. Sci. Sports Exec. 34(2), 364-380 (2002).
151. Klein S, Coyle EF, Wolfe RR: Fat metabolism during low-intensity exercise in endurance-trained and untrained men. Am. J. Physiol. 267(6 Pt 1), E934-E940 (1994).
152. Horowitz JF, Mora-Rodriguez R, Byerley LO, Coyle EF: Substrate metabolism when subjects are fed carbohydrate during exercise. Am. J. Physiol. 276(5 Pt 1), E828-E835 (1999).
153. Ormsbee MJ, Thyfault JP, Johnson EA, Kraus RM, Choi MD, Hickner RC: Fat metabolism and acute resistance exercise in trained men. J. Appl. Physiol. 102(5), 1767-1772 (2007).
154. Romijn JA, Coyle EF, Sidossis LS, Rosenblatt J, Wolfe RR: Substrate metabolism during different exercise intensities in endurance-trained women. J. Appl. Physiol. 88(5), 1707-1714 (2000).
155. Romijn JA, Coyle EF, Sidossis LS et al.: Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am. J. Physiol. 265(3 Pt 1), E380-E391 (1993).
156. Achten J, Jeukendrup AE: Optimizing fat oxidation through exercise and diet. Nutrition 20(7-8), 716-727 (2004).
157. Romijn JA, Coyle EF, Sidossis LS, Zhang XJ, Wolfe RR: Relationship between fatty acid delivery and fatty acid oxidation during strenuous exercise. J. Appl. Physiol. 79(6), 1939-1945 (1995).
158. Livesey G, Elia M: Estimation of energy expenditure, net carbohydrate utilization, and net fat oxidation and synthesis by indirect calorimetry: evaluation of errors with special reference to the detailed composition of fuels. Am. J. Clin. Nutr. 47(4), 608-628 (1988).
159. Wahrenberg H, Engfeldt P, Bolinder J, Arner P: Acute adaptation in adrenergic control of lipolysis during physical exercise in humans. Am. J. Physiol. 253(4 Pt 1), E383-E390 (1987).
160. Wahrenberg H, Bolinder J, Arner P: Adrenergic regulation of lipolysis in human fat cells during exercise. Eur. J. Clin. Invest. 21(5), 534-541 (1991).
161. Harant I, Marion-Latard F, Crampes F et al.: Effect of a long-duration physical exercise on fat cell lipolytic responsiveness to adrenergic agents and insulin in obese men. Int. J. Obes. Relat. Metab. Disord. 26(10), 1373-1378 (2002).
162. Savard R, Despres JP, Marcotte M, Theriault G, Tremblay A, Bouchard C: Acute effects of endurance exercise on human adipose tissue metabolism. Metabolism 36(5), 480-485 (1987).
163. Crampes F, Beauville M, Riviere D, Garrigues M, Lafontan M: Lack of desensitization of catecholamine-induced lipolysis in fat cells from trained and sedentary women after physical exercise. J. Clin. Endocrinol. Metab. 67(5), 1011-1017 (1988).
164. Klein S, Coyle EF, Wolfe RR: Effect of exercise on lipolytic sensitivity in endurance-trained athletes. J. Appl. Physiol. 78(6), 2201-2206 (1995).
165. Jensen MD: Lipolysis: contribution from regional fat. Annu. Rev. Nutr. 17, 127-139 (1997).
166. Jensen MD: Adipose tissue metabolism - an aspect we should not neglect? Horm. Metab. Res. 39(10), 722-725 (2007).
167. Despres JP, Bouchard C, Savard R, Tremblay A, Marcotte M, Theriault G: The effect of a 20-week endurance training program on adipose-tissue morphology and lipolysis in men and women. Metabolism 33(3), 235-239 (1984).
168. Despres JP, Bouchard C, Savard R, Tremblay A, Marcotte M, Theriault G: Effects of exercise-training and detraining on fat cell lipolysis in men and women. Eur. J. Appl. Physiol. Occup. Physiol. 53(1), 25-30 (1984).
169. Poehlman ET, Tremblay A, Marcotte M, Perusse L, Theriault G, Bouchard C: Heredity and changes in body composition and adipose tissue metabolism after short-term exercise-training. Eur. J. Appl. Physiol. Occup. Physiol. 56(4), 398-402 (1987).
170. Crampes F, Beauville M, Riviere D, Garrigues M: Effect of physical training in humans on the response of isolated fat cells to epinephrine. J. Appl. Physiol. 61(1), 25-29 (1986).
171. Wirth A, Diehm C, Hanel W, Welte J, Vogel I: Training-induced changes in serum lipids, fat tolerance, and adipose tissue metabolism in patients with hypertriglyceridemia. Atherosclerosis 54(3), 263-271 (1985).
172. Despres JP, Bouchard C, Savard R, Tremblay A, Marcotte M, Theriault G: Level of physical fitness and adipocyte lipolysis in humans. J. Appl. Physiol. 56(5), 1157-1161 (1984).
173. Despres JP, Bouchard C, Savard R, Prud'homme D, Bukowiecki L, Theriault G: Adaptive changes to training in adipose tissue lipolysis are genotype dependent. Int. J. Obes. 8(1), 87-95 (1984).
174. Mauriege P, Prud'homme D, Marcotte M, Yoshioka M, Tremblay A, Despres JP: Regional differences in adipose tissue metabolism between sedentary and endurance-trained women. Am. J. Physiol. 273(3 Pt 1), E497-E506 (1997).
175. De Glisezinski I, Crampes F, Harant I et al.: Endurance training changes in lipolytic responsiveness of obese adipose tissue. Am. J. Physiol. 275(6 Pt 1), E951-E956 (1998).
176. Romijn JA, Klein S, Coyle EF, Sidossis LS, Wolfe RR: Strenuous endurance training increases lipolysis and triglyceride-fatty acid cycling at rest. J. Appl. Physiol. 75(1), 108-113 (1993).
177. Riviere D, Crampes F, Beauville M, Garrigues M: Lipolytic response of fat cells to catecholamines in sedentary and exercise-trained women. J. Appl. Physiol. 66(1), 330-335 (1989).
178. Viru A, Toode K, Eller A: Adipocyte responses to adrenaline and insulin in active and former sportsmen. Eur. J. Appl. Physiol. Occup. Physiol. 64(4), 345-349 (1992).
179. Stallknecht B, Larsen JJ, Mikines KJ, Simonsen L, Bulow J, Galbo H: Effect of training on insulin sensitivity of glucose uptake and lipolysis in human adipose tissue. Am. J. Physiol Endocrinol. Metab. 279(2), E376-E385 (2000).
180. Qvisth V, Hagstrom-Toft E, Enoksson S, Moberg E, Arner P, Bolinder J: Human skeletal muscle lipolysis is more responsive to epinephrine than to norepinephrine stimulation in vivo. J. Clin. Endocrinol. Metab. 91(2), 665-670 (2006).
181. Jocken JW, Smit E, Goossens GH et al.: Adipose triglyceride lipase (ATGL) expression in human skeletal muscle is type I (oxidative) fiber specific. Histochem. Cell Biol. 129(4), 535-538 (2008).
182. Hickner RC, Racette SB, Binder EF, Fisher JS, Kohrt WM: Effects of 10 days of endurance exercise training on the suppression of whale body and regional lipolysis by insulin. J. Clin. Endocrinol. Metab. 85(4), 1498-1504 (2000).
183. Crampes F, Riviere D, Beauville M, Marceron M, Garrigues M: Lipolytic response of adipocytes to epinephrine in sedentary and exercise-trained subjects: sex-related differences. Eur. J. Appl. Physiol. Occup. Physiol. 59(4), 249-255 (1989).
184. Nicklas BJ, Rogus EM, Goldberg AP: Exercise blunts declines in lipolysis and fat oxidation after dietary-induced weight loss in obese older women. Am. J. Physiol. 273(1 Pt 1), E149-E155 (1997).
185. Klein S, Weber JM, Coyle EF, Wolfe RR: Effect of endurance training on glycerol kinetics during strenuous exercise in humans. Metabolism 45(3), 357-361 (1996).
186. Trapp EG, Chisholm DJ, Boutcher SH: Metabolic response of trained and untrained women during high-intensity intermittent cycle exercise. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293(6), R2370-R2375 (2007).
187. Stallknecht B, Simonsen L, Bulow J, Vinten J, Galbo H: Effect of training on epinephrine-stimulated lipolysis determined by microdialysis in human adipose tissue. Am. J. Physiol. 269(6 Pt 1), E1059-E1066 (1995).
188. Horowitz JF, Leone TC, Feng W, Kelly DP, Klein S: Effect of endurance training on. lipid metabolism in women: a potential role for PPARα in the metabolic response to training. Am. J. Physiol. Endocrinol. Metab. 279(2), E348-E355 (2000).
189. Friedlander AL, Casazza GA, Horning MA, Buddinger TF, Brooks GA: Effects of exercise intensity and training on lipid metabolism in young women. Am. J. Physiol. 275(5 Pt 1), E853-E863 (1998).
190. Horowitz JF, Braudy RJ, Martin WH III, Klein S: Endurance exercise training does not alter lipolytic or adipose tissue blood flow sensitivity to epinephrine. Am. J. Physiol. 277(2 Pt 1), E325-E331 (1999).
191. Phillips SM, Green HJ, Tarnopolsky MA, Heigenhauser GF, Hill RE, Grant SM: Effects of training duration on substrate turnover and oxidation during exercise. J. Appl. Physiol. 81(5), 2182-2191. (1996).
192. Martin WH III, Dalsky GP, Hurley BF et al.: Effect of endurance training on plasma free fatty acid turnover and oxidation during exercise. Am. J. Physiol. 265(5 Pt 1), E708-E714 (1993).
193. Stich V, De Glisezinski I, Galitzky J et al.: Endurance training increases the β-adrenergic lipolytic response in subcutaneous adipose tissue in obese subjects. Int. J. Obes. Relat. Metab. Disord. 23(4), 374-381 (1999).
194. De Glisezinski I, Moro C, Pillard F et al.: Aerobic training improves exercise-induced lipolysis in SCAT and lipid utilization in overweight men. Am. J. Physiol. Endocrinol. Metab. 285(5), E984-E990 (2003).
195. Martin WH III, Coyle EF, Joyner M, Santeusanio D, Ehsani AA, Holloszy JO: Effects of stopping exercise training on epinephrine-induced lipolysis in humans. J. Appl. Physiol. 56(4), 845-848 (1984).
196. Moro C, Pillard F, De Glisezinski I et al.: Training enhances ANP lipid-mobilizing action in adipose tissue of overweight men. Med. Sci. Sports Exerc. 37(7), 1126-1132 (2005).
197. Coggan AR, Raguso CA, Gastaldelli A, Sidossis LS, Yeckel CW: Fat metabolism during high-intensity exercise in endurance-trained and untrained men. Metabolism 49(1), 122-128 (2000).
198. Friedlander AL, Jacobs KA, Fattor JA et al.: Contributions of working muscle to whole body lipid metabolism are altered by exercise intensity and training. Am. J. Physiol. Endocrinol. Metab. 292(1), E107-E116 (2007).
199. Friedlander AL, Casazza GA, Horning MA, Usaj A, Brooks GA: Endurance training increases fatty acid turnover, but not fat oxidation, in young men. J. Appl. Physiol. 86(6), 2097-2105 (1999).
200. Langin D: Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol. Res. 53(6), 482-491 (2006).
201. Bajaj M, Suraamornkul S, Romanelli A et al.: Effect of a sustained reduction to plasma free fatty acid concentration on intramuscular long-chain fatty acyl-CoAs and insulin action in Type 2 diabetic patients. Diabetes 54(11), 3148-3153 (2005).
202. Rigazio S, Lehto HR, Tuunanen H et al.: The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans. Am. J. Physiol. Endocrinol. Metab. 295(2), E413-E4l9 (2008).
203. van Loon LJ, Manders RJ, Koopman R et al.: Inhibition of adipose tissue lipolysis increases intramuscular lipid use in Type 2 diabetic patients. Diabetologia 48(10), 2097-2107 (2005).